From IP to GMP: translating small RNA therapeutics into respiratory virus preventives
02 Dec 2025
Oligonucleotide CMC & Process Development
- Optimizing delivery systems for respiratory RNA therapeutics
- Stability and formulation challenges in respiratory administration
- From bench to GMP: translating RNA therapeutics
